newsfilter
← Latest News
GlobeNewswire·

Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation

FDA Agrees to Extended Milestones for Long-Term Twirla® Safety Study New Publication Supports Eventual Pursuit of AG200-15 Extended Regimen Development Program PRINCETON, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) --